Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
Ali Hassanzadeh, Majid Farshdousti Hagh, Mohammad Reza Alivand, et al.
Journal of Cellular Physiology (2018) Vol. 233, Iss. 10, pp. 6470-6485
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Shuling Song, Tamar Tchkonia, Jing Jiang, et al.
Advanced Science (2020) Vol. 7, Iss. 23
Open Access | Times Cited: 101
Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy
Javad Alizadeh, Simone C. da Silva Rosa, Xiaohui Weng, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 3, pp. 151337-151337
Open Access | Times Cited: 39
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 23
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
Bora Lim, Yoshimi Endo Greer, Stanley Lipkowitz, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1087-1087
Open Access | Times Cited: 68
Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methods
Hossein Mehralizadeh, Ahmad Nazari, Farshid Oruji, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154528-154528
Closed Access | Times Cited: 20
Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis through upregulation of death receptor 5
Yunyun Zhang, Linlin Wang, Chuxuan Dong, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 7
Closed Access | Times Cited: 6
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy
Javier Naval, Diego de Miguel, Ana Gallego-Lleyda, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 444-444
Open Access | Times Cited: 50
RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Nano-TRAIL: a promising path to cancer therapy
Siri Chandana Gampa
Cancer Drug Resistance (2023) Vol. 6, Iss. 1, pp. 79-103
Open Access | Times Cited: 13
Leukemia therapy by flavonoids: Future and involved mechanisms
Raedeh Saraei, Faroogh Marofi, Adel Naimi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8203-8220
Closed Access | Times Cited: 42
Flavonoid-Based Cancer Therapy: An Updated Review
Elham Hosseinzadeh, Ali Hassanzadeh, Faroogh Marofi, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 20, Iss. 12, pp. 1398-1414
Closed Access | Times Cited: 34
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
Patricia LoRusso, Mark J. Ratain, Toshihiko Doi, et al.
Investigational New Drugs (2022) Vol. 40, Iss. 4, pp. 762-772
Open Access | Times Cited: 20
Nanoparticle-Mediated Gene Delivery of TRAIL to Resistant Cancer Cells: A Review
Mina Habibizadeh, Shima Lotfollahzadeh, Parisa Mahdavi, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36057-e36057
Open Access | Times Cited: 4
c-FLIP regulates pyroptosis in retinal neurons following oxygen-glucose deprivation/recovery via a GSDMD-mediated pathway
Yanxia Huang, Shuchao Wang, Fei Huang, et al.
Annals of Anatomy - Anatomischer Anzeiger (2021) Vol. 235, pp. 151672-151672
Closed Access | Times Cited: 26
RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
Ehsan Razeghian, Ria Margiana, Supat Chupradit, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 25
Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4
Ismael Obaidi, Hilary Cassidy, Verónica Ibáňez Gaspar, et al.
Biology (2020) Vol. 9, Iss. 5, pp. 92-92
Open Access | Times Cited: 26
Anastasis: cell recovery mechanisms and potential role in cancer
Rebar N. Mohammed, Mohsen Khosravi, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Ceramides and Ceramide Synthases in Cancer: Focus on Apoptosis and Autophagy
Javad Alizadeh, Simone C. da Silva Rosa, Xiaohui Weng, et al.
(2023)
Open Access | Times Cited: 8
Investigating the synergistic potential of TRAIL and SAHA in inducing apoptosis in MOLT-4 cancer cells
Masoud Mohammad Mirzapour, Majid Farshdousti Hagh, Faroogh Marofi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 676, pp. 13-20
Closed Access | Times Cited: 7
Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms
Saleheh Rezapour, Elham Hosseinzadeh, Faroogh Marofi, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 11, pp. 19366-19383
Closed Access | Times Cited: 21
Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression
Ali Hassanzadeh, Adel Naimi, Majid Farshdousti Hagh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2019) Vol. 19, Iss. 15, pp. 1835-1845
Closed Access | Times Cited: 20
Codium fragile F2 sensitize colorectal cancer cells to TRAIL-induced apoptosis via c-FLIP ubiquitination
Seong Hye Park, Jung Lim Kim, Soyeon Jeong, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 508, Iss. 1, pp. 1-8
Closed Access | Times Cited: 20
Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells
Lin Lin, Dapeng Ding, Xiaoguang Xiao, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 12, pp. 6822-6832
Open Access | Times Cited: 17
Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors
Artem A. Artykov, Dmitry Belov, Victoria O. Shipunova, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1129-1129
Open Access | Times Cited: 16
miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications
Asma Safi, Milad Bastami, Soheila Delghir, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 9, pp. 1069-1081
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top